Share This

Public company info - Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.- H Shs , 00874.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.- H Shs, 00874.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12 2016-12 2015-12 2014-12 2013-12 2012-12 2011-12 2010-12 2009-12 2008-12 2007-12 2006-12 2005-12
Net Cash Flow from Operating Activities 9,758,406 8,546,847 3,223,075 8,021,028 5,216,888 1,833,691 2,444,672 1,941,956 3,471,589 2,724,707 1,985,399 198,609 100,720 430,028 104,920 524,389 140,561 238,886
Net Cash Flow from Return on Investments & Servicing of Finance -1,546,212 -1,325,964 -1,377,826 -1,089,331 -1,352,569 -484,778 -523,231 -401,247 -420,612 -55,902 -185,941 -46,702 9,362 17,709 -4,603 -132,627 -95,271 -67,340
　Interest Received 0 0 0 0 0 0 0 0 0 0 0 0 7,121 9,033 11,370 7,934 9,753 10,522
　Interest Paid 0 0 0 0 0 0 0 0 0 0 0 0 -1,544 -6,543 -10,197 -57,730 -46,275 -51,211
　Dividend Received 0 0 0 0 0 0 0 0 0 0 0 0 46,106 48,791 108,324 440 8,744 3,405
　Dividend Paid -1,546,212 -1,325,964 -1,377,826 -1,089,331 -1,352,569 -484,778 -523,231 -401,247 -420,612 -55,902 -185,941 -46,702 -42,321 -33,572 -114,100 -83,271 -67,493 -30,056
　Others 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Taxes (Paid) / Refunded -2,759,330 -2,873,351 -2,637,890 -2,998,661 0 0 0 0 -1,710,207 -1,385,566 -986,169 -383,649 -25,587 14,411 -59,665 -156,308 -113,709 -121,933
Net Cash Flow from Investing Activities -7,253,188 -931,569 -1,088,056 -1,028,395 1,109,718 -2,440,644 -249,158 -806,004 -287,420 -323,700 -66,094 -215,540 -31,005 49,284 -362,132 -88,272 -73,716 -96,039
　Additions to Fixed Assets -1,383,874 -1,254,917 -876,503 -2,399,811 -478,617 -196,771 -228,027 -515,342 -353,648 -350,346 -170,002 -53,876 -82,328 -86,145 -151,571 -121,384 -91,112 -125,290
　Disposal of Fixed Assets 1,495 6,614 6,146 1,116 1,497 850 18,060 539 479 4,004 2,579 753 14,376 1,068 2,302 2,226 5,710 1,230
　Increase in Investments -6,919,875 -403,557 -610,775 -356,098 -3,171,871 -4,848,445 -70,000 -367,400 0 -4,050 -2,620 -180,000 -1,147,868 -332,500 -3,500 0 -43,519 -200
　Decrease in Investments 684,674 477,518 427,720 1,585,561 3,814,828 124,473 22,475 74,223 68,850 0 0 5,000 1,168,322 305,000 -245,071 11,097 43,888 0
　Net Cash Flow with Related Parties 32,650 10,090 213,715 121,018 257,980 14,220 0 2,230 14,466 5,800 9,025 900 0 -30,000 0 100,860 0 0
　Others 331,742 232,683 -248,359 19,819 685,901 2,465,029 8,334 -254 -17,567 20,892 94,924 11,683 16,493 191,861 35,708 -81,071 11,317 28,221
Net Cash Flow before Financing Activities -1,800,324 3,415,964 -1,880,698 2,904,641 4,974,038 -1,091,731 1,672,283 734,705 1,053,350 959,539 747,195 -447,281 53,490 511,432 -321,480 147,182 -142,135 -46,426
Net Cash Flow from Financing Activities 1,592,162 -168,016 2,817,202 -1,142,482 -1,398,768 505 7,247,953 53,798 56,613 -155,787 -260,486 106,961 -24,502 -209,905 102,617 116,864 12,682 -217,378
　New Loans 9,695,998 8,826,175 8,917,817 7,118,767 2,101,109 18,249 288,034 717,774 753,177 587,332 959,438 177,808 38,868 145,422 338,175 1,250,020 1,137,401 1,341,918
　Loans Repayment -8,150,603 -8,657,267 -6,158,578 -7,698,792 -3,570,996 -31,964 -908,920 -656,998 -710,926 -750,271 -1,228,949 -71,747 -63,370 -325,327 -235,558 -1,200,276 -1,124,719 -1,621,923
　Fixed Income/Debt Instruments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
　Equity Financing 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 62,627
　Net Cash Flow with Related Parties 32,650 10,090 213,715 121,018 257,980 14,220 0 2,230 14,466 5,800 9,025 900 0 -30,000 0 100,860 0 0
　Others 14,117 -347,014 -155,752 -683,475 -186,861 0 7,868,839 -9,208 -104 1,352 0 0 0 0 0 -33,740 0 0
Increase(Decrease) in Cash & Cash Equivalents -208,162 3,247,948 936,505 1,762,159 3,575,270 -1,091,227 8,920,236 788,504 1,109,963 803,752 486,709 -340,320 28,988 301,527 -218,863 264,046 -129,453 -263,804
Cash & Cash Equivalents at Beginning of Year 21,013,364 17,765,133 16,833,623 15,071,612 11,495,535 12,586,470 3,837,604 3,049,529 1,918,952 1,114,347 626,289 696,347 667,385 365,859 585,046 489,128 618,581 882,385
Net Cash Flow due to Change in Exchange Rate/Others -503 283 -4,994 -148 807 292 -1,369 -429 220 854 1,348 -279 -26 -1 -324 0 0 0
Cash & Cash Equivalents at End of Year 20,804,699 21,013,364 17,765,133 16,833,623 15,071,612 11,495,535 12,756,470 3,837,604 3,029,136 1,918,952 1,114,347 355,749 696,347 667,385 365,859 753,174 489,128 618,581
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit Thousand Thousand Thousand Thousand Thousand Thousand Thousand
Auditor's Opinion 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.